BCM
MDP

Bayesian Capital Management’s Meredith Corporation MDP Stock Holding History

Bayesian Capital Management’s Portfolio MDP Stock Details MDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-5,723
Closed -$249K – 603
2021
Q2 		$249K Buy
+5,723
New +$203K 0.07% 324
2020
Q2 		– Sell
-19,900
Closed -$243K – 875
2020
Q1 		$243K Buy
+19,900
New +$529K 0.05% 526
2017
Q2 		– Sell
-7,000
Closed -$452K – 646
2017
Q1 		$452K Buy
+7,000
New +$431K 0.21% 183

Other funds holding MDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bayesian Capital Management's MDP Position: Q3 2021 in Review

Bayesian Capital Management sold out of Meredith Corporation (MDP) in Q3 2021, closing a stake of 5,723 shares — an estimated $249K sold.

Bayesian Capital Management first reported a position in MDP in Q1 2017 and held it in 3 quarters. The position peaked at $452K in Q1 2017. 217 funds tracked by Wall St. Rank hold MDP as of Q3 2021.

  • Bayesian Capital Management reported no remaining Meredith Corporation position as of Q3 2021 after selling out during the quarter.
  • Bayesian Capital Management sold 5,723 Meredith Corporation shares in Q3 2021, an estimated $249K.
  • Bayesian Capital Management first reported a position in Meredith Corporation in Q1 2017 and held it in 3 quarters.
  • Bayesian Capital Management's Meredith Corporation position peaked at $452K in Q1 2017.
  • 217 funds tracked by Wall St. Rank held Meredith Corporation as of Q3 2021.

Based on Bayesian Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.